MyMD Pharmaceuticals President Chris Chapman, M.D. Named Medical Honoree of the Year by the Arthritis Foundation
Cannabis Law Report
OCTOBER 26, 2021
Studies estimate that the number of people suffering from rheumatoid arthritis may rise to over 78 million by 2040. 1 Data published by Research and Markets, March 2018. The rising prevalence of rheumatoid arthritis, psoriatic arthritis, and inflammatory bowel disease are driving demand for TNF inhibitors like MYMD-1. 646) 421-9523.
52 
Let's personalize your content